Inventor · disambiguated record
Meyyappan Muthuppalaniappan
Also filed as: MUTHUPPALANIAPPAN MEYYAPPAN
34 granted patents·7 pending applications·171 citations·filing 2006–2023
97Inventor score
Files withRHIZEN PHARMACEUTICALS SA27MUTHUPPALANIAPPAN MEYYAPPAN6INCOZEN THERAPEUTICS PVT LTD4GLENMARK PHARMACEUTICALS SA2NAGARATHNAM DHANAPALAN1
Top patents by PatentIndex Score
41 records- 0197US9150579B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Oct 6, 2015·34 cites·14 claims
- 0296US9475818B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Oct 25, 2016·17 cites·20 claims
- 0394US10072013B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Sep 11, 2018·9 cites·20 claims
- 0494US9669033B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2016·Granted Jun 6, 2017·10 cites·15 claims
- 0593US8921364B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2012·Granted Dec 30, 2014·7 cites·23 claims
- 0693US8642607B24H-chromen-4-one compounds as modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Feb 4, 2014·17 cites·23 claims
- 0792US8912331B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2013·Granted Dec 16, 2014·17 cites·28 claims
- 0892US8377970B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2010·Granted Feb 19, 2013·7 cites·28 claims
- 0989US9018375B2Substituted chromenes as kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Apr 28, 2015·8 cites·5 claims
- 1086US8481739B23,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Jul 9, 2013·7 cites·47 claims
- 1185US10981919B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Granted Apr 20, 2021·1 cites·13 claims
- 1285US10570142B2Selective PI3K delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Feb 25, 2020·2 cites·29 claims
- 1385US9421209B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Aug 23, 2016·3 cites·13 claims
- 1484US10087182B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2017·Granted Oct 2, 2018·3 cites·9 claims
- 1583US9815831B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Nov 14, 2017·5 cites·32 claims
- 1681US10220035B2Compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Mar 5, 2019·2 cites·12 claims
- 1781US2024360095A1Novel kinase modulatorsRHIZEN PHARMACEUTICALS AG·Filed 2023·Application pending·0 cites
- 1880US9758514B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Sep 12, 2017·1 cites·47 claims
- 1980US8993612B2Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancerMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2010·Granted Mar 31, 2015·6 cites·14 claims
- 2080US8420689B2Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparationMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Apr 16, 2013·8 cites·21 claims
- 2178US11858907B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jan 2, 2024·0 cites·18 claims
- 2276US2021403475A1Novel selective pi3k delta inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 2375US9775841B2Compounds as modulators of protein kinasesNAGARATHNAM DHANAPALAN·Filed 2012·Granted Oct 3, 2017·2 cites·6 claims
- 2474US7923465B2Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparationGLENMARK PHARMACEUTICALS SA·Filed 2006·Granted Apr 12, 2011·3 cites·40 claims
- 2574US2021401840A1Novel compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 2670US11020399B2Intermediates useful in the synthesis of compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jun 1, 2021·0 cites·2 claims
- 2770US9758474B2Immunomodulator and anti-inflammatory compoundsRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Sep 12, 2017·1 cites·8 claims
- 2869US10668051B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jun 2, 2020·0 cites·20 claims
- 2969US10246450B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Apr 2, 2019·0 cites·19 claims
- 3069US8686048B2Immunomodulator and anti-inflammatory compoundsMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Apr 1, 2014·1 cites·7 claims
- 3168US2021371416A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 3267US9944631B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Apr 17, 2018·0 cites·15 claims
- 3364US10590129B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 3464US2015133449A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2014·Application pending·0 cites
- 3563US10538501B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2016·Granted Jan 21, 2020·0 cites·22 claims
- 3661US10322130B2Substituted chromenones as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Jun 18, 2019·0 cites·35 claims
- 3758US10442783B22,3-disubstituted chromen-4-one compounds as modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2010·Granted Oct 15, 2019·0 cites·33 claims
- 3855US11066402B23,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Jul 20, 2021·0 cites·19 claims
- 3954US2019248791A1Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancerRHIZEN PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 4045US10174034B2Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancerRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Jan 8, 2019·0 cites·5 claims
- 4144US2008200501A1Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparationGLENMARK PHARMACEUTICALS SA·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →